Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications

Nucleic acid aptamers generated through an in vitro selection are currently extensively applied as very valuable biomolecular tools thanks to their prominent advantages. Diversity of spatial structures, ease of production through chemical synthesis and a large variety of chemical modifications make aptamers convenient building blocks for the generation of multifunctional constructs. An opportunity to combine different aptamer functionalities with other molecules of interest such as reporter groups, nanoparticles, chemotherapeutic agents, siRNA or antisense oligonucleotides provides a widest range of applications of multivalent aptamers. The present review summarizes approaches to the design of multivalent aptamers, various examples of multifunctional constructs and the prospects of employing them as components of biosensors, probes for affinity capture, tools for cell research and potential therapeutic candidates.

[1]  Huan‐Tsung Chang,et al.  Highly efficient control of thrombin activity by multivalent nanoparticles. , 2011, Chemistry.

[2]  Weian Zhao,et al.  Bioinspired multivalent DNA network for capture and release of cells , 2012, Proceedings of the National Academy of Sciences.

[3]  J. McNamara,et al.  Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors , 2013, Clinical Cancer Research.

[4]  Ronghua Yang,et al.  Functional DNA-Containing Nanomaterials: Cellular Applications in Biosensing, Imaging, and Targeted Therapy , 2014, Accounts of chemical research.

[5]  G. Mayer,et al.  Multidomain Targeting Generates a High‐Affinity Thrombin‐Inhibiting Bivalent Aptamer , 2007, Chembiochem : a European journal of chemical biology.

[6]  Hua Shi,et al.  Composite RNA aptamers as functional mimics of proteins , 2009, Nucleic acids research.

[7]  Juewen Liu,et al.  Aptamer-based biosensors for biomedical diagnostics. , 2014, The Analyst.

[8]  Sonny C. Hsiao,et al.  Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. , 2009, Journal of the American Chemical Society.

[9]  Itamar Willner,et al.  Parallel Analysis of Two Analytes in Solutions or on Surfaces by Using a Bifunctional Aptamer: Applications for Biosensing and Logic Gate Operations , 2008, Chembiochem : a European journal of chemical biology.

[10]  Weihong Tan,et al.  Aptamer-conjugated multifunctional nanoflowers as a platform for targeting, capture, and detection in laser desorption ionization mass spectrometry. , 2013, ACS nano.

[11]  Shouzhuo Yao,et al.  Sensitive bifunctional aptamer-based electrochemical biosensor for small molecules and protein. , 2009, Analytical chemistry.

[12]  Dinshaw J. Patel,et al.  A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia , 2010, Nucleic acids research.

[13]  Y. Miyahara,et al.  Dual aptamer-immobilized surfaces for improved affinity through multiple target binding in potentiometric thrombin biosensing. , 2015, Biosensors & bioelectronics.

[14]  Kevin R. Shieh,et al.  A New Transferrin Receptor Aptamer Inhibits New World Hemorrhagic Fever Mammarenavirus Entry. , 2016, Molecular therapy. Nucleic acids.

[15]  Cuichen Wu,et al.  Building a multifunctional aptamer-based DNA nanoassembly for targeted cancer therapy. , 2013, Journal of the American Chemical Society.

[16]  Dihua Shangguan,et al.  Bifunctional combined aptamer for simultaneous separation and detection of thrombin. , 2010, Biosensors & bioelectronics.

[17]  Weian Zhao,et al.  A polyvalent aptamer system for targeted drug delivery. , 2013, Biomaterials.

[18]  Weian Zhao,et al.  Facile Supermolecular Aptamer Inhibitors of L-Selectin , 2015, PloS one.

[19]  Light-up fluorophore--DNA aptamer pair for label-free turn-on aptamer sensors. , 2016, Chemical communications.

[20]  Hua Shi,et al.  Commandeering a biological pathway using aptamer-derived molecular adaptors , 2010, Nucleic acids research.

[21]  Weihong Tan,et al.  Multivalent DNA nanospheres for enhanced capture of cancer cells in microfluidic devices. , 2013, ACS nano.

[22]  Genxi Li,et al.  Regulation of Thrombin Activity with a Bifunctional Aptamer and Hemin: Development of a New Anticoagulant and Antidote Pair , 2009, Chembiochem : a European journal of chemical biology.

[23]  Weihong Tan,et al.  Molecular assembly for high-performance bivalent nucleic acid inhibitor , 2008, Proceedings of the National Academy of Sciences.

[24]  T. Heyduk,et al.  Bivalent ligands with long nanometer-scale flexible linkers. , 2009, Biochemistry.

[25]  VorobyevaMariya,et al.  Aptamers Against Immunologic Targets: Diagnostic and Therapeutic Prospects , 2016 .

[26]  B. Sullenger,et al.  Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant. , 2016, Nucleic acid therapeutics.

[27]  M. Stojanović,et al.  Modular aptameric sensors. , 2004, Journal of the American Chemical Society.

[28]  Huan‐Tsung Chang,et al.  Gold nanoparticles modified with self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[29]  B. Sullenger,et al.  Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer. , 2008, Chemistry & biology.

[30]  X. Fang,et al.  Investigation of the interaction between a bivalent aptamer and thrombin by AFM. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[31]  Tao Wang,et al.  Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation , 2013, Sensors.

[32]  Weihong Tan,et al.  Engineering polymeric aptamers for selective cytotoxicity. , 2011, Journal of the American Chemical Society.

[33]  Hyejung Mok,et al.  Multivalent aptamer-RNA based fluorescent probes for carrier-free detection of cellular microRNA-34a in mucin1-expressing cancer cells. , 2015, Chemical communications.

[34]  C. Kuehne,et al.  Structural requirements of mono- and multivalent L-selectin blocking aptamers for enhanced receptor inhibition in vitro and in vivo. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[35]  E. SouleErin,et al.  Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant , 2016 .

[36]  G. Adams,et al.  Affinity and avidity in antibody-based tumor targeting. , 2009, Cancer biotherapy & radiopharmaceuticals.

[37]  G. King,et al.  Multitasking by Multivalent Circular DNA Aptamers , 2006, Chembiochem : a European journal of chemical biology.

[38]  K. Ley,et al.  L-selectin in inflammation, infection and immunity , 2005 .

[39]  Chia-Chen Chang,et al.  Disposable surface plasmon resonance aptasensor with membrane-based sample handling design for quantitative interferon-gamma detection. , 2014, Lab on a chip.

[40]  Hua Shi,et al.  An RNA-based transcription activator derived from an inhibitory aptamer , 2010, Nucleic acids research.

[41]  Yan Du,et al.  Multifunctional label-free electrochemical biosensor based on an integrated aptamer. , 2008, Analytical chemistry.

[42]  J. Lis,et al.  RNA aptamers as effective protein antagonists in a multicellular organism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Darmostuk,et al.  Current approaches in SELEX: An update to aptamer selection technology. , 2015, Biotechnology advances.

[44]  N. Stephanopoulos,et al.  Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. , 2010, ACS nano.

[45]  Keith E. Maier,et al.  From selection hits to clinical leads: progress in aptamer discovery , 2016, Molecular therapy. Methods & clinical development.

[46]  Harald Kolmar,et al.  Bi-specific Aptamers Mediating Tumor Cell Lysis , 2011, The Journal of Biological Chemistry.

[47]  Dayong Tian,et al.  Electrochemiluminescence biosensor for the assay of small molecule and protein based on bifunctional aptamer and chemiluminescent functionalized gold nanoparticles. , 2012, Analytica chimica acta.

[48]  Yi Xiao,et al.  Selection is more intelligent than design: improving the affinity of a bivalent ligand through directed evolution , 2012, Nucleic acids research.

[49]  P. Andreasen,et al.  Building a Molecular Trap for a Serine Protease from Aptamer and Peptide Modules. , 2016, Bioconjugate chemistry.

[50]  Hyundong Yoo,et al.  Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery. , 2014, Chemical communications.

[51]  Weihong Tan,et al.  Cancer cell targeting using multiple aptamers conjugated on nanorods. , 2008, Analytical chemistry.

[52]  B. Sullenger,et al.  Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40 , 2022 .

[53]  Danke Xu,et al.  Multifunctional aptamer-silver conjugates as theragnostic agents for specific cancer cell therapy and fluorescence-enhanced cell imaging. , 2015, Analytical chemistry.

[54]  D. H. Burke,et al.  Recombination, RNA evolution, and bifunctional RNA molecules isolated through chimeric SELEX. , 1998, RNA.

[55]  K. Ikebukuro,et al.  Methods for Improving Aptamer Binding Affinity , 2016, Molecules.

[56]  Gerald F. Joyce,et al.  Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA , 1990, Nature.

[57]  J. McNamara,et al.  Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. , 2008, The Journal of clinical investigation.

[58]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[59]  Koji Sode,et al.  Improvement of Aptamer Affinity by Dimerization , 2008, Sensors.

[60]  J. Bruno.  Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics , 2015, Molecules.

[61]  Youli Zu,et al.  A Highlight of Recent Advances in Aptamer Technology and Its Application , 2015, Molecules.

[62]  Weihong Tan,et al.  Aptamers from cell-based selection for bioanalytical applications. , 2013, Chemical reviews.

[63]  B. Sullenger,et al.  Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity. , 2003, Cancer research.

[64]  J. Lis,et al.  New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization , 2014, Molecular therapy. Nucleic acids.

[65]  Chao Liang,et al.  Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers , 2016, International journal of molecular sciences.

[66]  Tiantian Zhang,et al.  Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing , 2015, Sensors.

[67]  L. Cerchia,et al.  Oligonucleotide aptamers for glioma targeting: an update. , 2015, Central nervous system agents in medicinal chemistry.

[68]  N. Zhao,et al.  Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer. , 2013, Biomaterials.

[69]  B. Sullenger,et al.  Translation and Clinical Development of Antithrombotic Aptamers. , 2016, Nucleic acid therapeutics.

[70]  Hua Shi,et al.  RNA aptamers that functionally interact with green fluorescent protein and its derivatives , 2011, Nucleic acids research.

[71]  M. Kohara,et al.  Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3. , 2005, Journal of biochemistry.

[72]  J. Lis,et al.  A systematic study of the features critical for designing a high avidity multivalent aptamer. , 2013, Nucleic acid therapeutics.

[73]  G. King,et al.  Construction, Stability, and Activity of Multivalent Circular Anticoagulant Aptamers* , 2004, Journal of Biological Chemistry.

[74]  A. Kouzani,et al.  Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine , 2015, Theranostics.

[75]  Steve Scott,et al.  Streptavidin binding bifunctional aptamers and their interaction with low molecular weight ligands. , 2013, Analytica chimica acta.

[76]  Pascale Romby,et al.  High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands. , 2002, Nucleic acids research.

[77]  George M. Whitesides,et al.  Multivalency in Ligand Design , 2006 .

[78]  S. Esener,et al.  DeNAno: Selectable deoxyribonucleic acid nanoparticle libraries. , 2010, Journal of biotechnology.

[79]  Seung Soo Oh,et al.  Array-based Discovery of Aptamer Pairs , 2014, Analytical chemistry.

[80]  Z Hugh Fan,et al.  An ensemble of aptamers and antibodies for multivalent capture of cancer cells. , 2014, Chemical communications.

[81]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[82]  J. McNamara,et al.  Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[83]  Chia-Chen Chang,et al.  Amplified surface plasmon resonance immunosensor for interferon-gamma based on a streptavidin-incorporated aptamer. , 2012, Biosensors & bioelectronics.